Cargando…
Clinical Characteristics and Outcomes of Hematologic Malignancy Patients with Clostridium difficile Toxin EIA vs. PCR Positive Test Results
BACKGROUND: C. difficile infection is common in patients with hematologic malignancy. There is increasing recognition that molecular (polymerase chain reaction, PCR) based testing lacks specificity for infection, while detecting patients with colonization. The objective of our study was to evaluate...
Autores principales: | Ziegler, Matthew, Landsburg, Daniel, Pegues, David, Alby, Kevin, Gilmar, Cheryl, Bink, Kristen, Gorman, Theresa, Moore, Amy, Han, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631230/ http://dx.doi.org/10.1093/ofid/ofx163.987 |
Ejemplares similares
-
Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients With Hematologic Malignancy
por: Ziegler, Matthew, et al.
Publicado: (2019) -
1595. Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients with Hematologic Malignancy
por: Ziegler, Matthew, et al.
Publicado: (2018) -
2366. PCR Followed by Toxin EIA for the Diagnosis of C. difficile Infection
por: Zhang, Yu, et al.
Publicado: (2019) -
Clinical Correlation of a Clostridium difficile Testing Algorithm Reflexing PCR Positive Specimens to Toxin Enzyme Immunoassay (EIA)
por: Rios, Maria Bueno, et al.
Publicado: (2017) -
Can a toxin gene NAAT be used to predict toxin EIA and the severity of Clostridium difficile infection?
por: Garvey, Mark I., et al.
Publicado: (2017)